CFR

EQS-News: Successful refinancing and rating upgrade

Retrieved on: 
Wednesday, March 13, 2024
CFO, Moody's Investors Service, Growth, CFR, News, Security (finance)

Following its successful public listing on February 7, 2024, RENK Group AG also pushed ahead with the refinancing of its debt.

Key Points: 
  • Following its successful public listing on February 7, 2024, RENK Group AG also pushed ahead with the refinancing of its debt.
  • The €520m corporate bond (5.75% senior secured notes due 2025) was redeemed on February 20 and replaced by a €525m term loan from a consortium of banks.
  • On February 23, the rating agency Moody's raised the corporate rating (CFR) of RENK GmbH to Ba3 (from B1) and the outlook to "positive" (from "stable"), citing RENK's "relatively conservative and balanced financial policy" and "robust credit metrics" going forward.
  • The 5-year term gives us good visibility, while the extended guarantee facilities give us flexibility to further drive our growth," says Christian Schulz, CFO RENK Group AG, „The rating upgrade from Moody's confirms our view that we are solidly positioned on both the equity and debt side following the successful public listing."

SGS Expands Flammability Testing Services Across Aviation, Automotive and Maritime Sectors

Retrieved on: 
Thursday, March 7, 2024
Acquisition, NVIC, Aviation, USCG, Business development, CFR, SGS, Accreditation, ISO/IEC

SGS is pleased to announce the far-reaching expansion of its fire safety, resistance and flammability testing services at its laboratory in Farmingdale, New York, USA.

Key Points: 
  • SGS is pleased to announce the far-reaching expansion of its fire safety, resistance and flammability testing services at its laboratory in Farmingdale, New York, USA.
  • Geneva, Switzerland, Mar 7, 2024 - (ACN Newswire) - SGS, the world's leading testing, inspection and certification company, is pleased to announce the far-reaching expansion of fire safety, resistance and flammability testing services at its laboratory in Farmingdale, New York, USA.
  • As a leading provider of fire safety testing, SGS has gained approval from the United States Coast Guard (USCG) for an expanded scope of testing solutions for the maritime industry whilst also extending services provided within the framework of its ISO/IEC 17025:2017 accreditation.
  • "The broader capability builds on our expertise and SGS's 2017 acquisition of Govmark Testing Services to ensure that our clients, particularly from the aviation, automotive and maritime sectors, receive the highest level of service.

Velatura Announces Revolutionary Pilot Project with DocuSign to Streamline Patient Consent, Improve Efficiency

Retrieved on: 
Monday, March 11, 2024
Mental health, DocuSign, HDU, Empowerment, PHI, CFR, MHA, HIPAA, Part Two, Patient, HIE, Privacy, Michigan State University, QR, Partnership, Nursing

Secure and timely sharing of patient information between patients and providers is crucial for delivering coordinated care across diagnoses, treatments and healthcare settings.

Key Points: 
  • Secure and timely sharing of patient information between patients and providers is crucial for delivering coordinated care across diagnoses, treatments and healthcare settings.
  • “By joining forces with Velatura, we’re not only streamlining patient consent – we’re revolutionizing it,” said Robert Chatwani, President & General Manager of Growth at DocuSign.
  • Together, we are leveraging technology to streamline workflows and fundamentally reshape healthcare for the better.”
    The pilot project will begin rolling out to select Velatura network provider facilities this spring.
  • Velatura and DocuSign will be hosting a webinar titled, “Beyond Paperwork: Optimizing Patient Consent for Improved Healthcare Coordination,” with a panel discussion on March 19 at 1 p.m. ET/10 a.m. PT.

Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility

Retrieved on: 
Tuesday, March 5, 2024
Good manufacturing practice, Acquisition, Toxicity, Code, Neoplasm, Part, Cancer, CFR, CATX, LNTH, Therapy, TAT, Radiopharmaceutical, Patient, Clinical trial, Half-life, CGMP, Pharmaceutical industry

As a cGMP compliant facility, Perspective intends to utilize the facility to manufacture clinical supply of high quality 203Pb-labeled tumor-specific peptides to visualize and diagnose tumors, and 212Pb-labeled radiopharmaceuticals to treat target tumors with targeted alpha therapies (TAT).

Key Points: 
  • As a cGMP compliant facility, Perspective intends to utilize the facility to manufacture clinical supply of high quality 203Pb-labeled tumor-specific peptides to visualize and diagnose tumors, and 212Pb-labeled radiopharmaceuticals to treat target tumors with targeted alpha therapies (TAT).
  • The facility acquisition is part of a series of strategic agreements with Lantheus that Perspective announced on January 9, 2024, which included an initial equity investment in Perspective.
  • “We look forward to welcoming the exceptional talent at this facility and integrating them into our team,” said Shane Cobb, Executive Vice President of Operations, Perspective Therapeutics.
  • This is a significant milestone for Perspective as we build upon the progress we have made in establishing clinical manufacturing.”
    “We are thrilled to expand our manufacturing and supply chain infrastructure to include this facility capable of operating in compliance with Parts 212 and 211,” said Thijs Spoor, Chief Executive Officer, Perspective Therapeutics.

Old Glory Bank Continues Brisk Expansion and Announces Ownership Opportunity with a Public Private-Placement

Retrieved on: 
Friday, March 8, 2024
Banking, Professional Services, Finance, Regulation, Freedom, First State Bank, Bank, Friends, Growth, Silicon, Sale, FDIC, CFR, Government, Family, Constitution, Interview, Public, Insurance, Security (finance)

Old Glory Bank announced today they are again challenging the status quo by directly inviting accredited Americans in all 50 states to become an owner of Old Glory Bank.

Key Points: 
  • Old Glory Bank announced today they are again challenging the status quo by directly inviting accredited Americans in all 50 states to become an owner of Old Glory Bank.
  • Ring notes that once Old Glory has more than 2,000 stockholders, Old Glory Holding Company will begin typical filings under the Exchange Act of 1934.
  • If someone has not yet opened an account at Old Glory Bank, it takes just 8 minutes at www.oldglorybank.com .
  • To interview Mike Ring, Old Glory Bank’s President and CEO, contact Ms. Jules Wortman, at [email protected] or Kim Doster, at [email protected] .

Argonaut Manufacturing Services Expands Aseptic Pharmaceutical Fill / Finish Capabilities with $45 Million Equity Investment from NewVale Capital and Telegraph Hill Partners

Retrieved on: 
Tuesday, March 5, 2024
Packaging, Health, Manufacturing, Other Manufacturing, Pharmaceutical, Biotechnology, ISO, FDA, RBC Capital Markets, Syringe, CFR, Peptide, PMDA, Certification, Patient, Protein, Oligonucleotide

Argonaut Manufacturing Services (“Argonaut”), a leading contract development and manufacturing organization serving the biopharma and life sciences industries, announced today the completion of a $45 million financing to support its new drug product fill / finish expansion.

Key Points: 
  • Argonaut Manufacturing Services (“Argonaut”), a leading contract development and manufacturing organization serving the biopharma and life sciences industries, announced today the completion of a $45 million financing to support its new drug product fill / finish expansion.
  • Argonaut expects to have fully validated the facility and all equipment in 2025.
  • The financing was led by NewVale Capital, a growth equity fund focused on innovative pharmaceutical and life science services businesses, with participation from existing majority investor Telegraph Hill Partners, and other current investors.
  • “For years, small- and medium-sized biopharma companies have struggled to find reliable, high-quality fill / finish capabilities from providers that prioritize their molecules.

Rare Element Resources Announces Updated Mineral Resource for the Bear Lodge Project Focused on Key Magnet Materials

Retrieved on: 
Monday, March 4, 2024
Mining, Minerals, Natural Resources, Regulation S-K, Regulation, Technical report, 8-K, Growth, Electronics, Bear, TRS, Commodity, CFR, Engineering, National instrument, Mineral

There is no guarantee that any part of the mineral resource will be converted to mineral reserves in the future.

Key Points: 
  • There is no guarantee that any part of the mineral resource will be converted to mineral reserves in the future.
  • This mineral resource estimate is reported in accordance with Regulation S-K (CFR Title 17 Part 229 Items 1300-1305) at a cut-off grade of 2.18% TREO.
  • Commodity price assumptions used in the preparation of the mineral resource estimate are set forth in the TRS.
  • Rare Element Resources Ltd. is a publicly traded, strategic materials company focused on delivering rare earth products for technology, energy, and defense applications by advancing the Bear Lodge REE Project in northeast Wyoming.

MaxLinear Launches Single Chip for 5G Open RAN Radio Units

Retrieved on: 
Thursday, February 22, 2024
Data Management, Semiconductor, Technology, Mobile, Wireless, 5G, Networks, Hardware, DFE, Intermodulation, Algorithm, Federal Communications Commission, Architecture, Macro, FCC, DSS, SRAM, MXL, 33-centimeter band, Silicon, NB, Original equipment manufacturer, RAN, Picocell, Digital, MIMO, PIM, DDC, CFR, Radio, Ball grid array, DUC, Multimedia, Mobile World Congress, 3GPP, A53, DDR, System, DRAM, SOC, Congress, Gallium nitride, Heart, RF, SCS, DPD, RX, Software, PIMC, CPU, Video game

MaxLinear, Inc. (Nasdaq: MXL), a leader in wireless infrastructure silicon solutions, today announced it has launched the MXL17xxx family of devices (“Sierra”), a highly integrated SoC optimized for 4G/5G Open Radio Access Network (RAN) radio units (RU).

Key Points: 
  • MaxLinear, Inc. (Nasdaq: MXL), a leader in wireless infrastructure silicon solutions, today announced it has launched the MXL17xxx family of devices (“Sierra”), a highly integrated SoC optimized for 4G/5G Open Radio Access Network (RAN) radio units (RU).
  • Designers can rapidly build new macro and picocell O-RUs using just a single Sierra device by adding an appropriate RF front end.
  • “Open RAN momentum continues to build and is set to account for 20 percent to 30 percent of worldwide RAN revenues by 2028,” said Stefan Pongratz, Vice President and Analyst at the Dell’Oro Group.
  • MaxLinear will be conducting briefings on MaxLinear’s radio solutions at Mobile World Congress – Hall 2, meeting rooms 2A54MR and 2A63MR – from February 26 through February 29, 2024.

Netsmart Supports Whole-Person Care Provisions in 42 CFR Part 2 Final Rule

Retrieved on: 
Tuesday, February 20, 2024
Software, Practice Management, Telemedicine, Virtual Medicine, Managed Care, Health, Mental Health, Health Technology, Technology, Diabetes, SAMHSA, Senior, Roger Hawkins (drummer), Person, Record, Confidentiality, Part, Coronavirus, Substance Abuse, Partnership, Mental, CFR, Substance use disorder, Economy, HHS, HITECH, HIPAA, History, Health information technology, Part Two, OCR, Patient, Economic security, Privacy, Civil and political rights, DSM-IV codes, Accountability Act, Cancer, Medical device

Strengthens penalties by applying the same requirements of the HIPAA Breach Notification Rule to breaches of records under Part 2.

Key Points: 
  • Strengthens penalties by applying the same requirements of the HIPAA Breach Notification Rule to breaches of records under Part 2.
  • As a founding member of The Partnership to Amend 42 CFR Part 2 , Scalia stated the long-awaited Final Rule is another step forward for coordinated, whole-person care for individuals nationwide.
  • These major changes to 42 CFR Part 2 will take effect on February 16, 2026.
  • To learn more about these regulation changes, read the 42 CFR Part 2 Final Rule Fact Sheet and register for the upcoming Netsmart webinar on Thursday, March 28 at 1 p.m.

Radcliffe Group Selects Springer Healthcare for Reprint Sales to Pharmaceutical Industry

Retrieved on: 
Tuesday, March 5, 2024
AER, Interventional cardiology, Arrhythmia, Partnership, Life, CFR, Content, ECR, USC, Patient, Journal, Knowledge, Science, Springer Nature

BOURNE END, England, March 5, 2024 /PRNewswire-PRWeb/ -- Today Radcliffe Group, which brings the latest and best science, information, and knowledge to cardiovascular clinicians around the world, announced it has chosen Springer Healthcare in an exclusive deal to handle its reprints to buyers in the pharmaceutical industry. The deal was facilitated by content licensing specialist MEI Global, LLC (MEIG), a leader in helping publishers create new revenue streams through strategic third-party partnerships.

Key Points: 
  • BOURNE END, England, March 5, 2024 /PRNewswire-PRWeb/ -- Today Radcliffe Group, which brings the latest and best science, information, and knowledge to cardiovascular clinicians around the world, announced it has chosen Springer Healthcare in an exclusive deal to handle its reprints to buyers in the pharmaceutical industry.
  • Jonathan McKenna, Managing Director of Radcliffe Cardiology, says "Radcliffe strives to equip healthcare professionals with the skills and practical insights they need to do their best for patients by bringing the world's cardiovascular knowledge to life.
  • We are excited about partnering with Springer Healthcare and leveraging their established connections in the pharmaceutical market to aide us in that goal."
  • "A number of discussions and negotiations for complementary redistribution deals are also underway, and we're excited to help Radcliffe expand the audience for this powerful medical research."